2022 National Invitation for Myocardial Diagnostic Products Held in Sulpsida


In this warm summer, the 2022 National Investment Conference for Myocardial Diagnostic Products with the theme of "Science and Technology Empowerment, Fast Surpassing" was solemnly held in Nanjing Shupusida Medical Equipment Co., Ltd. This conference is jointly organized by Pushi Biotechnology Co., Ltd., Beijing Pulang Biotechnology Co., Ltd., Nanjing Pulang Medical Equipment Co., Ltd., Beijing Jiapu Yikang Biotechnology Co., Ltd., Chengdu Jinsen Biotechnology Co., Ltd., and Nanjing Shupusida Medical Equipment Co., Ltd.

Visit the showroom and company

Before the meeting, the leaders of Pulang Group and the distinguished guests visited the company's exhibition hall and factory area, and learned about the corporate culture, awards, honors, and product technology.

Visit the exhibition hall

Visit the exhibition hall

Visit the company

Sign in

 

Meeting site

Meeting site

Product display

The meeting began

The leaders attending this meeting include chairman Liu Jinhu, general manager Tang Xuefeng of Nanjing Shupusida Medical Equipment Co., Ltd., executive deputy general manager Bai Chuanchuan of Nanjing Shupusida Medical Equipment Co., Ltd., Chun Lin, head of investment section of Pulang Group, Zhu Yanhua, deputy general manager of Nanjing Pulang Medical Equipment Co., Ltd., and Dr. Wang Lin, general manager of Pulang Biotechnology (Beijing) Co., Ltd. (online attendance), hou Wei, Deputy General Manager of Pushi Biotechnology (Beijing) Co., Ltd.

Chairman Liu Jinhu

Nanjing Shupusida Medical Equipment Co., Ltd.
General Manager Tang Xuefeng

Nanjing Shupusida Medical Equipment Co., Ltd.

Executive Deputy General Manager Baichuan Chuan

Chun Lin, Head of Investment Section, Pulang Group

Nanjing Pulang Medical Equipment Co., Ltd.

Deputy General Manager Zhu Yanhua

Pushi Biotechnology (Beijing) Co., Ltd.

Dr. Lin Wang, General Manager (Online)

Pushi Biotechnology (Beijing) Co., Ltd.

Deputy General Manager Hou Wei

Host Zhang Shukai


At the meeting, Mr. Bai Chuan, Executive Deputy General Manager of Nanjing Shupusida Medical Equipment Co., Ltd. made an opening speech.

Shupusida Executive Deputy General Manager Bai Chuan Chuan speech


Myocardial Diagnostic Project Series Product Introduction

"Myocardial Diagnosis Project" Series Product Introduction

Dr. Wang Lin, general manager of Pushi Biotechnology Co., Ltd., introduced a series of products of "myocardial diagnosis project" online, so that everyone can have a comprehensive and in-depth understanding of myocardial diagnosis related products.

Introduction of Cooperation Mode and Investment Policy

Introduction of Cooperation Mode and Investment Policy

Zhu Yanhua, deputy general manager of Nanjing Pulang Medical Equipment Co., Ltd., interpreted the "Introduction to Cooperation Methods and Investment Promotion Policies" for everyone. Good products cannot be separated from good policies, and good policies support good products.


Looking to the future


Group photo as a souvenir

The good and happy time is always short. While everyone talks about the future and seeks common development, the 2022 National Merchants Association for Myocardial Diagnostic Products has also come to an end.
Through this meeting, guests and partners from afar will have a more detailed understanding of our group's general companies, high-quality products and good investment promotion policies. It is hoped that through this meeting, we will usher in in in-depth cooperation, develop hand in hand, open up a win-win situation, create a brilliant future together, and realize a more magnificent blueprint!

Nanjing Shupusida Medical Equipment Co., Ltd. has always been adhering to the mission of "focusing on scientific and technological innovation, making every breath of life more powerful", with the vision of "being the light of China in the future medical treatment", and truly achieving "ingenuity inheritance, intelligent manufacturing" A new medical enterprise in the future.